DBV Technologies S.A.
DBVTNasdaqCIK 1613780HealthcareFiscal year ends Dec 31
Reports and events: 335 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2817:24 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-436411 |
| 2026-10-2816:54 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001628280-26-067930 |
| 2026-09-3021:18 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-408052 |
| 2026-07-1617:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-306222 |
| 2026-07-1616:08 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-048453 |
| 2026-06-2916:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-288533 |
| 2026-06-0516:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-259488 |
| 2026-06-0316:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-255414 |
| 2026-05-1106:55 ET | DEF 14A | Proxy statementPeriod 2026-06-03 | 0001193125-26-215657 |
| 2026-05-0516:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-206315 |
| 2026-04-3017:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-197921 |
| 2026-04-3016:24 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-028929 |
| 2026-04-3016:03 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001193125-26-197148 |
| 2026-03-2617:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-126671 |
| 2026-03-2617:18 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-021504 |
| 2026-03-0207:54 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-084251 |
| 2026-01-2020:29 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-015592 |
| 2026-01-1417:36 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-003806 |
| 2026-01-0716:01 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-001744 |
| 2026-01-0516:02 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-000611 |
| 2025-12-1918:32 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-123340 |
| 2025-12-1616:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-320901 |
| 2025-11-0416:14 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-106287 |
| 2025-10-3016:49 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-258780 |
| 2025-10-2917:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-253968 |
| 2025-10-2816:44 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-046809 |
| 2025-09-1816:42 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-207507 |
| 2025-09-0516:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-197277 |
| 2025-07-2917:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-168148 |
| 2025-07-2916:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001613780-25-000016 |
| 2025-06-2516:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-146994 |
| 2025-06-1116:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-139137 |
| 2025-05-1516:06 ET | DEF 14A | Proxy statementPeriod 2025-06-11 | 0001193125-25-120788 |
| 2025-05-1416:05 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001193125-25-119836 |
| 2025-04-3016:46 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-107505 |
| 2025-04-3016:02 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001613780-25-000011 |
| 2025-04-2817:09 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001193125-25-100826 |
| 2025-04-1116:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001613780-25-000006 |
| 2025-04-0716:50 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-032674 |
| 2025-03-3119:35 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-030053 |
| 2025-03-3116:02 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-068727 |
| 2025-03-2407:01 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-060850 |
| 2025-01-0817:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-003574 |
| 2024-12-1816:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-281283 |
| 2024-12-1616:06 ET | 8-K | 3.01 Delisting notice | 0001193125-24-279571 |
| 2024-12-1116:42 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-275646 |
| 2024-11-1207:30 ET | 8-K | 3.03 Change to security holders’ rights; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-255153 |
| 2024-11-0617:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-252203 |
| 2024-11-0616:34 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001613780-24-000007 |
| 2024-10-2216:53 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-241114 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 05:16 ET. Listed shows no prices and gives no investment advice.